The Patent Finder
BL

Bicycletx Limited

First filing 2018
OverviewNotableFeesChangesFamiliesPatent listSources & methods

33 patents currently held

1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Dec 2037. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Dec 2037
Next term end
22
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 11, 2027
    The maintenance fee for Bicyclic Peptide Ligands Specific for EPHA2 (US 11,696,956) comes due Jan 11, 2027. Unpaid by Jul 12, 2027, it lapses early.
  • 1 fee due Feb 22, 2027
    The maintenance fee for Peptide Derivatives Having Novel Linkage Structures (US 11,730,819) comes due Feb 22, 2027. Unpaid by Aug 23, 2027, it lapses early.
  • 1 fee due Jun 5, 2027
    The maintenance fee for Methods of Suppression and Treatment of Disease Comprising administering Bicycle Peptide Ligands Specific for EphA2 (US 11,833,211) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
  • 2 fees due Aug 20 to 27, 2027 · next Aug 20
  • 2 fees due Oct 30, 2027

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 5 largest of its 22 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 11,730,819Peptide Derivatives Having Novel Linkage Structures
In force
 · Medium confidence
In forceMedium confidence
US 11,433,137Compounds for Treating Cancer
In force
 · High confidence
In forceHigh confidence
US 10,857,196Bicyclic Peptide Ligands and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,261,214Bicyclic Peptide Ligand Specific for CD137
In force
 · High confidence
In forceHigh confidence
US 12,049,520Bicyclic Peptide Ligands Specific for CD137
In force
 · Medium confidence
In forceMedium confidence
US 12,630,588Bicyclic Peptide Ligands Specific for CD137
In force
 · Low confidence
In forceLow confidence
US 11,484,602BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2
In force
 · High confidence
In forceHigh confidence
US 11,696,956Bicyclic Peptide Ligands Specific for EPHA2
In force
 · High confidence
In forceHigh confidence
US 11,833,211Methods of Suppression and Treatment of Disease Comprising administering Bicycle Peptide Ligands Specific for EphA2
In force
 · High confidence
In forceHigh confidence
US 10,875,894Multimeric Bicyclic Peptide Ligands
In force
 · High confidence
In forceHigh confidence
10 of 33 patents shown.
Pro members see all 33.
Pro members: see all 33 patents
Also on record, not counted in the 33: 1 patent in force now held by others · 3 patents ended · 36 applications pending · 27 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited